Low-dose oral minoxidil in a case of short anagen syndrome
Purpose This study aims to explore the effectiveness of low-dose oral minoxidil (LDOM) in treating short anagen hair syndrome (SAS), a rare congenital condition characterized by a shortened anagen phase. While SAS often resolves spontaneously with puberty, treatment remains controversial. Recent stu...
Saved in:
Main Authors: | Divija Sharma, Serena Morsia, Benjamin Ungar |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/09546634.2025.2460580 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
by: Eman Hamed El Morsy, et al.
Published: (2025-01-01) -
Cosmetic filler-induced hair loss: case series and literature review
by: Yutong Xie, et al.
Published: (2024-12-01) -
Progress on mitochondria and hair follicle development in androgenetic alopecia: relationships and therapeutic perspectives
by: Ting-ru Dong, et al.
Published: (2025-02-01) -
Recalcitrant Female Pattern Hair Loss Like Alopecia Unveils Unexpected Rare Entity
by: Nouh AH, et al.
Published: (2025-01-01) -
Effectiveness of autologous growth factor concentrates combined with topical minoxidil in patients of androgenic alopecia
by: Lavanya Maripati, et al.
Published: (2025-01-01)